"Competition Heats Up With Latest Tests For Thyroid Nodules" - Miriam E. Tucker
New data on the latest versions of two top genomic sequencing classifiers (GSC) demonstrate the increasing ability of molecular testing to assist in the management of patients with thyroid nodules of indeterminate cytology. Gregory Dodell, MD, assistant clinical professor of medicine, endocrinology, diabetes and bone disease at the Icahn School of Medicine at Mount Sinai, works with a surgeon who uses ThyroSeq. “As a clinician, when I get that report, it’s great. It’s so comprehensive and it makes me feel I’m doing the right thing for the patient.” Dr. Dodell doesn’t do the biopsies himself, so the surgeon’s preference is important. "If I send him my patients, I want him to use the test he's most comfortable making decisions on. I always admire and trust a surgeon who says a patient doesn't need surgery...He uses this information to spare the patient."
- Gregory Dodell, MD, Assistant Clinical Professor, Medicine, Endocrinology, Diabetes and Bone Disease, Icahn School of Medicine at Mount Sinai